Southern Cross Pharma Pty Ltd - søkeresultat

southern cross pharma pty ltd - moxonidine, quantity: 200 microgram - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; crospovidone; povidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-moxonidine moxonidine 400 microgram film-coated tablet blister pack

southern cross pharma pty ltd - moxonidine, quantity: 400 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; crospovidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-clonidine clonidine hydrochloride 100 micrograms tablet bottle

southern cross pharma pty ltd - clonidine hydrochloride, quantity: 100 microgram - tablet - excipient ingredients: maize starch; hyprolose; calcium hydrogen phosphate dihydrate; lactose monohydrate; microcrystalline cellulose; allura red ac; magnesium stearate; colloidal anhydrous silica - oral: all grades of essential hypertension. renal hypertension.,the prophylactic management of migraine or recurrent vascular headaches which occur in adult patients with a frequency of more than once a month and are not adequately relieved by appropriate therapy for the acute attack. alleviation of symptoms due to localised vasodilatation in menopausal flushing.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

letrozole fbm letrozole 2.5 mg tablet blister pack

southern cross pharma pty ltd - letrozole -